NEWS & DEALS
Done Deals.

Search by

Kinstellar advises Dream Games on its USD 50 million Series A Round investment in Turkey

March 2021 – Kinstellar has successfully advised the Turkish technology start-up Dream Games on its USD 50 million Series A Round investment, with Index Ventures as the lead investor.

Kinstellar advises the Hungarian medical device manufacturer Medicor on investment in Turkey

February 2021 – Kinstellar has successfully advised the Hungarian medical device manufacturer Medicor on its EUR 2 million investment for incubator production in the Turkish capital Ankara. The project is Hungary's first direct investment in the medical...

Kinstellar advises Doğuş Holding on the sale of a 30% stake in Istanbul’s premier shopping mall, Istinye Park, to Qatar Holding LLC

December 2020 – Kinstellar has successfully advised the Turkish conglomerate Doğuş Holding on the sale of a 30% stake in the premier Istanbul shopping mall, Istinye Park, to the Doha-based investment house Qatar Holding LLC.

Kinstellar advises Turkey Wealth Fund on the merger control approval for its acquisition of a controlling interest in Turkcell

October 2020 – Kinstellar’s Kyiv office has successfully advised Türkiye Varlık Fonu (Turkey Wealth Fund) in connection with obtaining the merger control approval from the Antimonopoly Committee of Ukraine for the acquisition of a controlling interest...

Kinstellar advises Vivense, the leading Turkish online furniture retailer, in relation to a USD 130 million investment by Actera

July 2020 – Kinstellar has assisted Vivense and its CEO and founder, Kemal Erol, in relation to a USD 130 million investment by Actera Group, the largest private equity firm focusing on investments in Turkey.

Kinstellar advises Earlybird Venture Capital on the seed funding round to the fintech startup Payhawk

March 2020 – Kinstellar’s teams in Istanbul and Sofia have successfully represented Earlybird Venture Capital on the €3 million seed funding to the fintech startup Payhawk, the paperless corporate card that simplifies expenses for businesses. This...

Kinstellar advises Arkema on the acquisition of Den Braven

August 2016 – Kinstellar advised Arkema SA, a global innovative chemical company, on the acquisition of the Dutch sealant-and-adhesives maker Den Braven from Egeria, a Benelux buyout house, in a deal valued at EUR 485 million. The transaction was managed...

Kinstellar advises Bayer AG on the spin-off of Covestro, Germany’s largest IPO in more than eight years

October 2015 – Kinstellar is pleased to announce that it was part of yet another landmark transaction in recent months. We advised Bayer, one of the major players in the pharmaceutical industry, on the carve-out of Bayer Material Science, into a separate...